Satter Management
Latest statistics and disclosures from Satter Management's latest quarterly 13F-HR filing:
Tip: Access up to 7 years of quarterly data
Positions held by Satter Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Satter Management
Satter Management holds 7 positions in its portfolio as reported in the June 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| American Well Corp Cl A (AMWL) | 50.5 | $27M | 6.3M | 4.32 | ||
| Annexon (ANNX) | 13.7 | $7.4M | 2.0M | 3.77 | ||
| Assembly Biosciences (ASMB) | 8.7 | $4.7M | 2.2M | 2.10 | ||
| Aadi Bioscience (AADI) | 8.6 | $4.6M | 375k | 12.32 | ||
| Aileron Therapeutics (ALRN) | 8.0 | $4.3M | 17M | 0.26 | ||
| Global Blood Therapeutics In (GBT) | 7.5 | $4.0M | 126k | 31.95 | ||
| Akebia Therapeutics (AKBA) | 3.0 | $1.6M | 4.7M | 0.35 |
Past Filings by Satter Management
SEC 13F filings are viewable for Satter Management going back to 2020
- Satter Management 2022 Q2 filed Aug. 4, 2022
- Satter Management 2022 Q1 filed May 13, 2022
- Satter Management 2021 Q4 filed Feb. 9, 2022
- Satter Management 2021 Q3 filed Nov. 15, 2021
- Satter Management 2021 Q2 filed Aug. 11, 2021
- Satter Management 2021 Q1 filed May 12, 2021
- Satter Management 2020 Q4 filed Feb. 11, 2021